|  | Cancer | Brain Cancer

Understanding Stage 3 Cancer: TNM Staging & Lung Cancer

Clarification: Stage 3D

There is no "Stage 3D" in standard TNM staging (AJCC 8th edition). The user likely means Stage III (Roman numeral 3) with subcategories (IIIA, IIIB, IIIC). "D" may be a typo for "III" or confusion with other systems.

TNM Staging Basics

  • T (Tumor): Size, invasion depth.
  • N (Nodes): Regional lymph node involvement.
  • M (Metastasis): Distant spread (M0 = none, M1 = yes).

Stage grouping combines T/N/M into stages I–IV.

Lung Cancer (NSCLC) Stage III

Locally advanced, heterogeneous. Substages:

Substage Typical T/N/M Clinical Implication
IIIA T1-3 N2 M0 / T3-4 N1 M0 Potentially resectable (multimodal); N2 = ipsilateral mediastinal nodes
IIIB T1-2 N3 M0 / T3-4 N2 M0 Generally unresectable; N3 = contralateral/supraclavicular nodes
IIIC T3-4 N3 M0 Advanced local invasion + contralateral nodes; definitive chemoradiation

Key Features of Stage III NSCLC

  • No distant metastases (M0).
  • Lymph node involvement central (N2/N3).
  • Tumor may invade chest wall, diaphragm, mediastinum, great vessels (T3/T4).
  • Standard: Concurrent chemoradiation → consolidation immunotherapy (durvalumab) if no progression.
  • 5-year OS: ~30–50% depending on substage, performance status, molecular profile.

Bladder Cancer Stage III

Muscle-invasive (T3/T4a) ± nodal involvement.

Stage TNM Description
IIIA T3a/b N0 M0 / T1-3a N1 M0 Perivesical fat or single regional node
IIIB T1-3a N2-3 M0 / T4a N0-1 M0 Multiple nodes, common iliac, or prostate/uterus/vagina invasion
IIIC T4b N0-1 M0 / T4b N2-3 M0 Pelvic/abdominal wall invasion ± nodes

Standard: Neoadjuvant cisplatin-based chemo → radical cystectomy (+ pelvic lymphadenectomy) or trimodal therapy (TURBT + chemoradiation).

Important Notes

  • Staging varies by cancer type (e.g., breast, colon have different III definitions).
  • AJCC updates every ~5–7 years; always confirm edition.
  • Clinical vs. pathologic staging differ (cTNM vs. pTNM).
  • Molecular markers (EGFR, ALK, PD-L1 in lung; FGFR, ERBB2 in bladder) increasingly guide therapy beyond stage.

Bottom Line

"Stage 3D" is not standard terminology. For lung or bladder cancer, Stage III (with A/B/C substages) indicates locally advanced disease with nodal involvement but no distant mets. Treatment is multidisciplinary and increasingly personalized.

Brain Cancer - Related Articles